CNBG’s Inactivated Coronavirus Vaccine Program Wins Gold Prize at the First MSTOC

The Development Center for Medical Science and Technology under the National Health Commission of China held the first Medical Science and Technology Innovation Competition (MSTOC) this year, with an aim to fuel innovation in medical science and technology, build a medical innovation ecosystem, strengthencoordination and cooperation of high-caliber medical professionals, research institutions, leading enterprises and academic organizations, sift out medical innovations with the greatest influence and potential, facilitate information exchange related to medical science and technology, and promote industrialization of excellent research projects.

Sinopharm Chairman Liu Jingzhen Attends State Council Press Conference to Introduce the Latest Coronavirus Vaccine Progress

The Joint Prevention and Control Mechanism of the State Council held a press conference at 3 p.m. on October 20. Liu Jingzhen, chairman of China National Pharmaceutical Group Co., Ltd. (Sinopharm), attended the press conference to introduce the latest progress in the development of COVID-19 vaccine.

The Lancet Publishes Data of Phase I/II Clinical Trial for CNBG Beijing Institute’s COVID-19 Vaccine

51 African Envoys and Senior Diplomats Visit CNBG Beijing Institute

Since the beginning of this year, the COVID-19 outbreak has brought grave challenges to the world. In the spirit of solidarity and cooperation, China and Africa helped each other to wade through this difficult time. In October, China and African countries welcomed an important moment—the 20th anniversary of the Forum on China-Africa Cooperation.